Statins as Antiarrhythmics: A Systematic Review Part II: Effects on Risk of Ventricular Arrhythmias

被引:18
作者
Abuissa, Hussam
O'Keefe, James H. [1 ]
Bybee, Kevin A. [2 ]
机构
[1] Univ Missouri, Kansas City, MO 64110 USA
[2] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA
关键词
LIPID-LOWERING DRUGS; IMPLANTABLE DEFIBRILLATORS; MYOCARDIAL-INFARCTION; HEART-FAILURE; THERAPY; SIMVASTATIN; MORTALITY; PRAVASTATIN; SURVIVAL; EVENTS;
D O I
10.1002/clc.20435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies have demonstrated that statins may possess antiarrhythmic properties in addition to their lipid-lowering effects. Methods: Studies which reported the association of statins with the incidence of ventricular arrhythmias were identified through a systematic review of the published literature. Results: Statins have been associated with significant reduction in ventricular arrhythmia in cardiomyopathy patients with an implantable cardioverter defibrillator, although randomized trials have not been completed. Conclusions: Published data suggest that statins may possess antiarrhythmic properties that reduce the propensity for ventricular arrhythmias. Most of this data is observational; more randomized, placebo-controlled trials are needed.
引用
收藏
页码:549 / 552
页数:4
相关论文
共 23 条
[1]  
Budaj A, 1996, EUR HEART J, V17, P1506
[2]   Reduced creatine kinase release with statin use at the time of myocardial infarction [J].
Bybee, KA ;
Kopecky, SL ;
Williams, BA ;
Murphy, JG ;
Wright, RS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 96 (03) :461-466
[3]   Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator [J].
Chiu, JH ;
Abdelhadi, RH ;
Chung, MK ;
Gurm, HS ;
Marrouche, NF ;
Saliba, WI ;
Natale, A ;
Martin, DO .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (04) :490-491
[4]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[5]   Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients [J].
De Sutter, J ;
Tavernier, R ;
De Buyzere, M ;
Jordaens, L ;
De Backer, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :766-772
[6]   Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts [J].
Di Napoli, P ;
Taccardi, AA ;
Grilli, A ;
Spina, R ;
Felaco, M ;
Barsotti, A ;
De Caterina, R .
CARDIOVASCULAR RESEARCH, 2001, 51 (02) :283-293
[7]   Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) [J].
Dickinson, Michael G. ;
Ip, John H. ;
Shansky, Brian ;
Hellkamp, Anne S. ;
Anderson, Jill ;
Poole, Jeanne E. ;
Mark, Daniel B. ;
Lee, Kerry L. ;
Bardy, Gust H. .
AMERICAN HEART JOURNAL, 2007, 153 (04) :573-578
[8]   Statins and mortality among elderly patients hospitalized with heart failure [J].
Foody, JM ;
Shah, R ;
Galusha, D ;
Masoudi, FA ;
Havranek, EP ;
Krumholz, HM .
CIRCULATION, 2006, 113 (08) :1086-1092
[9]   Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy [J].
Goldberger, Jeffrey J. ;
Subacius, Haris ;
Schaechter, Andi ;
Howard, Adam ;
Berger, Ronald ;
Shalaby, Alaa ;
Levine, Joseph ;
Kadish, Alan H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (06) :1228-1233
[10]   Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure [J].
Horwich, TB ;
MacLellan, WR ;
Fonarow, GC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :642-648